Discover 1,092 paid clinical trials in South Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Carolina has a wide range of paid research studies actively seeking both healthy volunteers and those with particular health conditions. Major hubs in Charleston, Columbia, and Greenville provide access to innovative treatments and top-quality medical care.
Filter
1
Filter results
Results: 1,092
Prediction Augmented Screening Initiative
for
Lung Cancer, Lung Cancer Screening
Location: Charleston SC
Sponsor: VA Office of Research and Development
Sex: All
Age: 50 - 70+
Code: NCT06538636
Recruiting
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
for
Graves Disease
Location: Morehead City NC, Greenville NC, Wilmington NC,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 70
Code: NCT07661056
Phase3, Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: St. John's, Portsmouth NH, Brighton MA, Milford MA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
for
Pneumococcal Disease
Location: Fall River MA, East Syracuse NY, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 1 - 17
Code: NCT07660198
Phase3, Recruiting
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
for
Non-Arteritic Anterior Ischemic Optic Neuropathy
Location: Boston MA, Philadelphia PA, Durham NC, Charleston SC,
Sponsor: Dompé Farmaceutici S.p.A
Sex: All
Age: 50 - 70+
Code: NCT07453888
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
for
Hypercholesterolaemia
Location: Lanham MD, Ft. Washington MD, Richmond VA, Manassas VA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07610278
Phase2, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Hawthorne NY, The Bronx NY, Ocean City NJ, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
for
Actinic Keratosis (AK)
Location: Charleston SC, Manhattan Beach CA
Sponsor: Avant Health LLC
Sex: All
Age: 18+
Code: NCT07657988
Recruiting
Mobile Supportive Teams for Reinforcing Increased Daily Exercise Study
for
Physical Activity
Location: Columbia SC
Sponsor: University of South Carolina
Sex: All
Age: 18+
Code: NCT06662292
Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Boston MA, New York NY, Gainsville FL, Greenville SC,
Sponsor: Recross Cardio, Inc.
Sex: All
Age: 18 - 65
Code: NCT07172464
Recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
for
Hypercholesterolemia
Location: Wilmington NC, Charlottesville VA, Durham NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07477704
Phase2, Recruiting
Clareon TruPlus Study
for
Aphakia, Astigmatism
Location: Mt. Pleasant SC, Brecksville OH, Sugar Land TX,
Sponsor: Alcon Research
Sex: All
Age: 22+
Code: NCT07502456
Recruiting
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Location: Methuen MA, New York NY, Rockville MD, Miami FL,
Sponsor: Tonix Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07621237
Phase2, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease